{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:55:02Z","timestamp":1782816902536,"version":"3.54.5"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1T32DA037801-01"],"award-info":[{"award-number":["1T32DA037801-01"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.drugpo.2016.02.007","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T07:27:51Z","timestamp":1456558071000},"page":"3-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5799-1736","authenticated-orcid":false,"given":"Phillip L.","family":"Marotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte A.","family":"McCullagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2016.02.007_bib0005","first-page":"8","article-title":"Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: A modeling analysis for Ukraine","author":"Alistar","year":"2011","journal-title":"PLoS Medicine"},{"issue":"1","key":"10.1016\/j.drugpo.2016.02.007_bib0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.drugalcdep.2011.05.034","article-title":"Prevalence, characteristics, and predictors of police training initiatives by US SEPs: Building an evidence base for structural interventions","volume":"119","author":"Beletsky","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"10.1016\/j.drugpo.2016.02.007_bib0015","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2105\/AJPH.2015.302681","article-title":"Police encounters among needle exchange clients in Baltimore: Drug law enforcement as a structural determinant of health","volume":"105","author":"Beletsky","year":"2015","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0020","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1097\/QAI.0000000000000638","article-title":"Structural interventions for HIV prevention among women who use drugs: A global perspective","volume":"69","author":"Blankenship","year":"2015","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"9","key":"10.1016\/j.drugpo.2016.02.007_bib0025","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1360-0443.2004.00694.x","article-title":"Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities","volume":"99","author":"Bluthenthal","year":"2004","journal-title":"Addiction"},{"issue":"6122","key":"10.1016\/j.drugpo.2016.02.007_bib0295","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1126\/science.1230413","article-title":"Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment","volume":"339","author":"Bor","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.drugpo.2016.02.007_bib0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugpo.2009.10.004","article-title":"Methadone as HIV prevention: High volume methadone sites to decrease HIV incidence rates in resource limited settings","volume":"21","author":"Bruce","year":"2010","journal-title":"International Journal of Drug Policy"},{"issue":"11","key":"10.1016\/j.drugpo.2016.02.007_bib0040","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0277-9536(98)00449-3","article-title":"Beyond the biomedical and behavioural: Towards an integrated approach to HIV prevention in the southern African mining industry","volume":"48","author":"Campbell","year":"1999","journal-title":"Social Science & Medicine"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0045","series-title":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Harm reduction: Evidence, impacts and challenges","article-title":"The diffusion of harm reduction in Europe and beyond","author":"Cook","year":"2010"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0050","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1097\/QAI.0b013e3182217f00","article-title":"Game changers: Why did the scale-up of HIV treatment work despite weak health systems?","volume":"57","author":"De Cock","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"9810","key":"10.1016\/j.drugpo.2016.02.007_bib0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"Degenhardt","year":"2012","journal-title":"The Lancet"},{"issue":"9737","key":"10.1016\/j.drugpo.2016.02.007_bib0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","article-title":"Prevention of HIV infection for people who inject drugs: Why individual, structural, and combination approaches are needed","volume":"376","author":"Degenhardt","year":"2010","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.drugpo.2016.02.007_bib0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2105\/AJPH.85.1.10","article-title":"Harm reduction \u2013 A framework for incorporating science into drug policy","volume":"85","author":"Des Jarlais","year":"1995","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0065","first-page":"S217","article-title":"Measuring harm reduction: The effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV","volume":"12","author":"Drucker","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0075","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/01.aids.0000298105.79484.62","article-title":"Scale-up of HIV care and treatment: Can it transform healthcare services in resource-limited settings?","volume":"21","author":"El-Sadr","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0305","series-title":"Harm reduction in Europe: Mapping coverage and civil society advocacy","author":"European Harm Reduction Network","year":"2015"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0080","unstructured":"European Monitoring Center for Drugs and Drug Addiction. (2015). http:\/\/www.emcdda.europa.eu\/index.cfm."},{"issue":"2","key":"10.1016\/j.drugpo.2016.02.007_bib0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2006.11.006","article-title":"Harm reduction theory: Users\u2019 culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users\u2019 groups","volume":"18","author":"Friedman","year":"2007","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"10.1016\/j.drugpo.2016.02.007_bib0090","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1360-0443.1993.tb02081.x","article-title":"Discriminating needle exchange attenders from non-attenders","volume":"88","author":"Frischer","year":"1993","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.drugpo.2016.02.007_bib0095","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00002030-200107270-00002","article-title":"Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users","volume":"15","author":"Gibson","year":"2001","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.drugpo.2016.02.007_bib0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0955-3959(02)00224-4","article-title":"Modelling emerging HIV epidemics: The role of injecting drug use and sexual transmission in the Russian Federation, China and India","volume":"14","author":"Grassly","year":"2003","journal-title":"International Journal of Drug Policy"},{"issue":"4","key":"10.1016\/j.drugpo.2016.02.007_bib0110","doi-asserted-by":"crossref","first-page":"e1001625","DOI":"10.1371\/journal.pmed.1001625","article-title":"Changes in HIV incidence among people who inject drugs in Taiwan following introduction of a harm reduction program: A study of two cohorts","volume":"11","author":"Huang","year":"2014","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0115","series-title":"The global state of harm reduction 2012: Towards an integrated response","author":"IHRA","year":"2012"},{"issue":"7481","key":"10.1016\/j.drugpo.2016.02.007_bib0120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bmj.38286.841227.7C","article-title":"Incidence of hepatitis C virus and HIV among new injecting drug users in London: Prospective cohort study","volume":"330","author":"Judd","year":"2004","journal-title":"British Medical Journal"},{"issue":"3\u20134","key":"10.1016\/j.drugpo.2016.02.007_bib0125","first-page":"88","article-title":"Syringe source, use, and discard among injection-drug users in New Haven, Connecticut","volume":"15","author":"Khoshnood","year":"2000","journal-title":"AIDS & Public Policy Journal"},{"issue":"2","key":"10.1016\/j.drugpo.2016.02.007_bib0130","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/01.qai.0000127054.60503.9a","article-title":"Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies","volume":"37","author":"Kral","year":"2004","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0135","series-title":"Introducing multilevel modeling","author":"Kreft","year":"1998"},{"issue":"9723","key":"10.1016\/j.drugpo.2016.02.007_bib0140","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(10)60233-4","article-title":"Public financing of health in developing countries: A cross-national systematic analysis","volume":"375","author":"Lu","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0145","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis","volume":"345","author":"MacArthur","year":"2012","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","article-title":"Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness","volume":"25","author":"Macarthur","year":"2014","journal-title":"International Journal on Drug Policy"},{"issue":"3","key":"10.1016\/j.drugpo.2016.02.007_bib0155","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/sw\/49.3.353","article-title":"Harm reduction: A new perspective on substance abuse services","volume":"49","author":"MacMaster","year":"2004","journal-title":"Social Work"},{"issue":"9651","key":"10.1016\/j.drugpo.2016.02.007_bib0160","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"The Lancet"},{"issue":"97191","key":"10.1016\/j.drugpo.2016.02.007_bib0310","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage","volume":"375","author":"Mathers","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0165","first-page":"10","article-title":"Evidence links increases in public health spending to declines in preventable deaths","author":"Mays","year":"2011","journal-title":"Health Affairs"},{"issue":"2","key":"10.1016\/j.drugpo.2016.02.007_bib0170","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jurban\/79.2.257","article-title":"Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges","volume":"79","author":"Miller","year":"2002","journal-title":"Journal of Urban Health"},{"issue":"2","key":"10.1016\/j.drugpo.2016.02.007_bib0175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1521\/aeap.2007.19.2.124","article-title":"Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program","volume":"19","author":"Millson","year":"2007","journal-title":"AIDS Education & Prevention"},{"issue":"12","key":"10.1016\/j.drugpo.2016.02.007_bib0180","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2105\/AJPH.89.12.1852","article-title":"Syringe vending machines for injection drug users: An experiment in Marseille, France","volume":"89","author":"Obadia","year":"1999","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0185","series-title":"Exploring the effects of health care on mortality across OECD countries Labour Market and Social Policy Occasional-Papers No. 46","author":"Or","year":"2000"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0190","series-title":"Determinants of health outcomes in industrialized countries: A pooled, cross-country, time-series analysis. OECD Economic Studies: No. 30, 2000\/1","author":"Or","year":"2000"},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2016.02.007_bib0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/heapro\/dal048","article-title":"Gender and health promotion: A multisectoral policy approach","volume":"21","author":"\u00d6stlin","year":"2006","journal-title":"Health Promotion International"},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2016.02.007_bib0200","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/QAI.0b013e3181bbcb56","article-title":"Civil society, political mobilization, and the impact of HIV scale-up on health systems in Brazil","volume":"52","author":"Parker","year":"2009","journal-title":"Journal of Acquired Immune Deficiency Syndromes (1999)"},{"issue":"5","key":"10.1016\/j.drugpo.2016.02.007_bib0205","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11606-002-0037-2","article-title":"The impact of needle exchange-based health services on emergency department use","volume":"17","author":"Pollack","year":"2002","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0210","series-title":"Multilevel and longitudinal modeling using Stata","author":"Rabe-Hesketh","year":"2008"},{"issue":"1","key":"10.1016\/j.drugpo.2016.02.007_bib0215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00126334-200005010-00010","article-title":"Comparing new participants of a mobile versus a pharmacy-based needle exchange program","volume":"24","author":"Riley","year":"2000","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"1","key":"10.1016\/j.drugpo.2016.02.007_bib0220","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2105\/AJPH.88.1.34","article-title":"Retention, HIV risk, and illicit drug use during treatment: Methadone dose and visit frequency","volume":"88","author":"Rhoades","year":"1998","journal-title":"American Journal of Public Health"},{"issue":"1","key":"10.1016\/j.drugpo.2016.02.007_bib0315","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0277-9536(02)00521-X","article-title":"Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment","volume":"57","author":"Rhodes","year":"2003","journal-title":"Social science & Medicine"},{"issue":"3","key":"10.1016\/j.drugpo.2016.02.007_bib0225","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00126334-200403010-00011","article-title":"Injecting equipment sharing among injecting drug users in Togliatti City, Russian Federation: Maximizing the protective effects of syringe distribution","volume":"35","author":"Rhodes","year":"2004","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"2","key":"10.1016\/j.drugpo.2016.02.007_bib0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","article-title":"The \u2018risk environment\u2019: A framework for understanding and reducing drug-related harm","volume":"13","author":"Rhodes","year":"2002","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0235","series-title":"Multilevel analysis","first-page":"879","author":"Snijders","year":"2011"},{"issue":"1","key":"10.1016\/j.drugpo.2016.02.007_bib0320","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0376-8716(99)00104-0","article-title":"Drug abuse treatment as an HIV prevention strategy: a review","volume":"59","author":"Sorensen","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.drugpo.2016.02.007_bib0240","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11524-010-9438-4","article-title":"Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: The impact of buprenorphine treatment","volume":"87","author":"Springer","year":"2010","journal-title":"Journal of Urban Health"},{"issue":"9737","key":"10.1016\/j.drugpo.2016.02.007_bib0245","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0140-6736(10)60743-X","article-title":"HIV and risk environment for injecting drug users: The past, present, and future","volume":"376","author":"Strathdee","year":"2010","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.drugpo.2016.02.007_bib0325","doi-asserted-by":"crossref","first-page":"e19048","DOI":"10.1371\/journal.pone.0019048","article-title":"Social and structural factors associated with HIV infection among female sex workers who inject drugs in the Mexico-US border region","volume":"6","author":"Strathdee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0250","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1097\/QAI.0000000000000624","article-title":"Substance use and HIV among female sex workers and female prisoners: Risk environments and implications for prevention, treatment, and policies","volume":"69","author":"Strathdee","year":"2015","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"3","key":"10.1016\/j.drugpo.2016.02.007_bib0255","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF02386744","article-title":"Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area","volume":"77","author":"Thiede","year":"2000","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0330","unstructured":"United Nations Office on Drugs and Crime, (2015)."},{"key":"10.1016\/j.drugpo.2016.02.007_bib0260","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam cohort studies among drug users","volume":"102","author":"Van Den Berg","year":"2007","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.drugpo.2016.02.007_bib0265","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/01.olq.0000221335.80508.fa","article-title":"The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine","volume":"33","author":"Vickerman","year":"2006","journal-title":"Sexually Transmitted Diseases"},{"issue":"5","key":"10.1016\/j.drugpo.2016.02.007_bib0270","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00042560-199712150-00014","article-title":"Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program","volume":"16","author":"Vlahov","year":"1997","journal-title":"JAIDS \u2013 Journal of Acquired Immune Deficiency Syndromes"},{"issue":"4","key":"10.1016\/j.drugpo.2016.02.007_bib0275","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/00952999609001677","article-title":"Retention in methadone maintenance is associated with reductions in different HIV risk behaviors for women and men","volume":"22","author":"Wells","year":"1996","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0280","series-title":"Data","author":"World Bank","year":"2015"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0285","series-title":"Needle and syringe programs","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.drugpo.2016.02.007_bib0290","unstructured":"World Health Organization, Regional Office For Europe, European Center for Disease Prevention and Control. [Dataset], (2015) http:\/\/www.euro.who.int\/en\/home."}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395916300159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395916300159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T16:56:12Z","timestamp":1536944172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395916300159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":63,"alternative-id":["S0955395916300159"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2016.02.007","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2016.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}